OakChart

Astrana Health Inc

ASTHHealthcare·Medical Care Facilities·USA·Small·NASD·Nov 11 • 7:05 AM ET

37.76+5.58 (17.35%)
2026-11-11 14:43 CET
Market cap
1,596.27 USD m
Revenue, TTM
3,911.76 USD m
Net income, TTM
53.13 USD m
Free cash flow, TTM
99.42 USD m
EPS diluted, TTM
1.07
P/E
35.25
Compare

Price

ASTH against its 20, 50 and 200-day averages
2050200beatmiss
30.0040.0050.00981K2.0MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ASTHclose 37.7620-day 36.8850-day 36.76200-day 34.2437.76

26.8% under 51.60 on 2 Jul 2026. Last 15 sessions, 30.6% high to low

Profile

ASTH
52-week range, 59% of the way up
18.0851.60

Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. It operates as an integrated healthcare delivery platform, providing services like Primary Care, Multi-Specialty Care, Immediate Care, Radiology, and Laboratory. The company was founded by Kenneth Sin and Thomas S. Lam in 1985 and is headquartered in Alhambra, CA.

IndexRUT
Employees3000
IPOOct 23, 2006
Beta1.26
ATR, 14d2.42
Rel volume0.01
Short float7.89%
Insider own23.50%
Inst own66.28%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.87B
Enterprise Value2.23B
Income53.13M
Sales3.91B
Book/sh17.37
Cash/sh8.03
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees3000
IPOOct 23, 2006

Ratios

P/E35.25
Forward P/E19.59
PEG0.25
P/S0.48
P/B2.17
P/C4.70
P/FCF18.84
EV/EBITDA12.09
EV/Sales0.57
Quick Ratio1.25
Current Ratio1.25
Debt/Eq1.14
LT Debt/Eq1.06
Option/ShortYes / Yes

Earnings

EPS (ttm)1.07
EPS next Y1.93
EPS next Q0.25
EPS this Y187.41%
EPS next Y45.77%
EPS next 5Y77.49%
EPS past 3/5Y-22.81% -14.74%
Sales past 3/5Y40.62% 35.87%
EPS Y/Y TTM463.11%
Sales Y/Y TTM35.05%
EPS Q/Q3360.00%
Sales Q/Q7.07%
EarningsNov 05 AMC
EPS/Sales Surpr.-43.16% 0.35%

Ownership

Insider Own23.50%
Insider Trans0.00%
Inst Own66.28%
Inst Trans4.78%
ROA2.32%
ROE6.51%
ROIC3.01%
Gross Margin9.34%
Oper. Margin3.10%
Profit Margin1.36%
SMA202.39%
SMA502.72%
SMA20010.30%
Trades-

Technical

Shs Outstand49.32M
Shs Float37.95M
Short Float7.89%
Short Ratio7.76
Short Interest2.99M
52W High51.60 -26.82%
52W Low18.08 108.86%
Volatility10.17% 5.37%
ATR (14)2.42
RSI (14)53.21
Beta1.26
Rel Volume0.01
Avg Volume385.74K
Volume161

Performance

Perf Week-4.81%
Perf Month-0.28%
Perf Quarter-0.07%
Perf Half Y-5.02%
Perf YTD52.21%
Perf Year58.67%
Perf 3Y25.04%
Perf 5Y-64.05%
Perf 10Y739.17%
Recom1.36
Target Price51.89
Prev Close32.18
Price37.76
Change %17.35%

Analyst ratings

latest 10 of 18
DateActionAnalystRating changeTargetImplied
Sep 15, 2026InitiatedOOppenheimerOutperform$53+40.4%
May 26, 2026UpgradeBBarclaysEqual Weight → Overweight$50+32.4%
Dec 12, 2025InitiatedNNeedhamBuy$28-25.9%
Apr 01, 2025InitiatedBBarclaysEqual Weight$36-4.7%
Oct 14, 2024InitiatedTTD CowenBuy$66+74.8%
Oct 11, 2024InitiatedKKeyBanc Capital MarketsSector Weight
Jul 11, 2024UpgradeTTruistHold → Buy$44 → $50+32.4%
May 30, 2024InitiatedRRobert W. BairdOutperform$54+43.0%
Feb 26, 2024InitiatedJJefferiesBuy$50+32.4%
Feb 22, 2024UpgradeBBofA SecuritiesNeutral → Buy$44 → $55+45.6%

Peers

Mkt cap
TickerCompanyMkt cap
AGLAgilon Health Inc1.91B
PRVAPrivia Health Group Inc3.11B
ALHCAlignment Healthcare Inc1.59B
INNVInnovAge Holding Corp1.27B
PIIIP3 Health Partners Inc23.02M
EVHEvolent Health Inc542.91M
CLOVClover Health Investments Corp2.59B
NUTXNutex Health Inc1.28B
UNHUnitedhealth Group Inc361.01B
HUMHumana Inc52.44B

Insider trading

4 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Schmidt DavidDirectorAug 14 '26Option Exercise5.0020,000100,00056,019Aug 18 04:15 PM
Sim BrandonCEO and PresidentFeb 02 '26Option Exercise23.2421,334495,8021,045,329Feb 03 09:37 PM
Schmidt DavidDirectorJan 13 '26Option Exercise5.7920,000115,80035,763Jan 15 04:15 PM
Lam Thomas S.DirectorDec 08 '25Option Exercise17.7829,502524,546459,122Dec 10 04:15 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.63B
VTIVanguard Morningstar Total Stock Market ETFAUM: 689.41B
IWMiShares Russell 2000 Index FundAUM: 78.30B
VBVanguard Morningstar Small-Cap ETFAUM: 79.96B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.56B
VXFVanguard Extended Market Index ETFAUM: 30.61B
IWOiShares Russell 2000 Growth ETFAUM: 14.20B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.57B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.11B
IJSiShares S&P Small-Cap 600 Value ETFAUM: 7.76B

News

latest 14 of 206
  • Foothill Regional Medical Center Recognized Among Healthgrades' 2027 America's 100 Best Hospitals for Orthopedic Surgery and Joint Replacement (PR Newswire) +17.35%
  • Astrana Health Misses Consensus As Record EBITDA Meets Unchanged Guidance And Worsening Medicaid Costs (Earnings Whispers) -11.56%
  • Astrana Health, Inc. Reports Third Quarter 2026 Results (PR Newswire)
  • Astrana Health's Q3 Test: Can Cost Trend And Medicaid Attrition Spare The EBITDA Raise? (Earnings Whispers)
  • Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference Call (PR Newswire)
  • Loading…
  • Astrana Health Inc (ASTH) (Q2 2026) Earnings Call Highlights: Record EPS and Raised Guidance ... (GuruFocus.com)
  • Astrana Health, Inc. Reports Second Quarter 2026 Results (PR Newswire)
  • Astrana Health, Inc. Schedules 2026 Second Quarter Financial Results Release and Conference Call (PR Newswire)
  • Astrana Health Strengthens Leadership Team to Accelerate Long-Term Growth (PR Newswire)
  • Astrana Health ACOs Deliver $120.4 Million in Gross Shared Savings in 2024 Performance Year (PR Newswire)
  • Astrana Health Named to the 2026 Fortune 1000 List Following Strong Revenue Growth (PR Newswire)
  • Astrana Health, Inc. Announces Appointment of Interim National Medical Director (PR Newswire)
  • Physician Association of California and Astrana Health Launch Collaboration to Strengthen Independent Primary Care (PR Newswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-050.2600.4570.2601,0241,02011
2026Q22026-08-060.4000.3360.397972.5982.2310
2026Q12026-05-070.2900.2990.294965.1949.2111
2025Q42026-03-020.1200.1060.121950.53930.4310
2025Q32025-11-060.0100.4660.008956.05952.836
2025Q22025-08-070.1900.3490.191654.81638.339
2025Q12025-05-080.1400.2070.137620.39630.6810
2024Q42025-02-27-0.1500.099-0.145665.21617.2410
2024Q32024-11-070.3300.3090.334478.71462.419
2024Q22024-08-070.4000.3930.400486.27447.478
2024Q12024-05-070.3100.3030.311404.36413.846
2023Q42024-02-270.2600.1480.260353.04341.176
2023Q32023-11-070.4700.3300.470348.17349.494
2023Q22023-08-070.2800.2490.282348.21341.973
2023Q12023-05-080.3100.3070.280337.24318.073
2022Q42023-02-23-0.060-0.070-0.056294.21247.352

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY0.3900.4000.388560.62535.54
2020FY1.0100.9201.011687.18674.9
2021FY1.6301.5901.518773.92755.06
2022FY1.0801.0450.9911,1441,097
2023FY1.2901.1801.2931,3871,375
2024FY0.9001.1360.8992,0351,987
2025FY0.4600.4930.4603,1823,161
2026FY-1.322--3,975
2027FY-1.927--4,376
2028FY-2.572--4,829
2029FY-3.230--5,121
2030FY-3.760--5,553

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0910021,0169981,035
2026Q4S2026-11-0610021,0169981,035
2026Q4S2026-11-0510001,024999.631,067
2026Q4S2026-10-2110001,024999.631,067
2026Q4S2026-09-1410031,024999.631,067
2026Q4S2026-09-1110031,024999.631,067
2026Q4S2026-08-189031,024999.631,067
2026Q4S2026-08-168031,0271,0031,067
2026Q4S2026-08-149031,023995.321,067
2026Q4S2026-08-079031,023995.321,067
2026Q4S2026-08-059001,035995.321,105
2026Q4S2026-08-0410001,033995.321,105
2026Q4S2026-07-2510001,032995.321,105
2026Q4S2026-07-2210101,032995.321,105

Estimate history

EPS, annual0.90.2860.3881.0111.5180.9911.2930.8990.4561.0714
Period201720182019202020212022202320242025TTM
EPS, quarterly0.334-0.1450.1370.1910.0080.1210.2940.3970.26
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual357.747519.908560.618687.18773.9151144.1631386.6612034.543181.7693911.76
Period201720182019202020212022202320242025TTM
Sales, quarterly478.71665.209620.39654.808956.048950.526965.1972.521023.616
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual32.30534.57835.90842.24944.63146.57646.84447.9348.88549.32
Period201720182019202020212022202320242025MRQ
Shares, quarterly47.78147.9349.02949.13949.38448.88548.94649.22749.32
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue3,911.763,181.772,034.541,386.661,144.16773.91687.18560.62519.91
Cost of Goods Sold Incl. D&A3,546.462,885.991,791.081,189.45962.23613.66557.56486.09380.44
Gross Profit365.31295.78243.46197.21181.94160.26129.6274.53139.47
Selling, General and Administrative Excl. Other244.18217.26154.11112.6077.6762.0849.1240.1247.24
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income121.1278.5389.3584.61104.2798.1880.5034.4192.23
Interest Expense64.6449.9333.1016.107.925.399.504.730.56
Unusual Expense-7.710.07-0.744.5821.2710.74-99.841.993.80
Net Income Before Taxes86.6539.6180.8289.8486.6277.75178.4325.8482.63
Income Taxes28.2315.5330.8931.9940.8831.6956.118.1722.36
Consolidated Net Income58.4124.0849.9357.8545.7446.05122.3217.6760.27
Net Income From Continuing Operations53.1322.4943.1560.7245.1768.9237.8714.1210.84
Net Income53.1322.4943.1560.7245.1768.9237.8714.1210.84
EPS (Recurring)0.960.460.891.361.321.68-0.860.430.36
EPS (Basic, Before Extraordinaries)1.080.460.911.301.001.571.040.410.33
EPS (Diluted)1.070.460.901.290.991.521.010.390.29
EBITDA184.18124.27117.28102.36121.81115.7098.8552.69111.53
Non-Operating Income (Expense)22.4511.0823.8225.9111.54-4.297.58-1.85-5.24
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense38.4230.4927.2817.4112.724.922.470.440.64
Price To Earnings Ratio30.0430.0424.1739.2620.8245.3918.6448.6771.48
Price To Sales Ratio0.450.380.741.301.184.311.001.201.45
Gross Margin9.349.3011.9714.2215.9020.7118.8613.2926.83
Operating Margin3.102.474.396.109.1112.6911.716.1417.74
Net Margin1.360.712.124.383.958.915.512.522.08
Shares Outstanding49.3248.8947.9346.8446.5844.6342.2535.9134.58
Market Capitalization1,596.271,596.271,548.752,232.261,678.453,266.51672.15642.37676.59

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue1,023.62972.52965.10950.53956.05654.81620.39665.21
Cost of Goods Sold Incl. D&A915.69884.05874.84871.88874.45583.74555.91622.86
Gross Profit107.9388.4790.2778.6481.6071.0664.4842.35
Selling, General and Administrative Excl. Other68.0554.1561.7460.2562.3950.7343.9041.63
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income39.8834.3228.5318.3919.2120.3420.580.72
Interest Expense15.0216.0016.1017.5217.727.387.318.07
Unusual Expense-1.13-4.73-1.08-0.770.81-0.010.04-0.32
Net Income Before Taxes32.2227.2119.717.515.6716.829.60-1.90
Income Taxes11.958.766.580.944.596.613.385.88
Consolidated Net Income20.2718.4513.136.561.0810.226.22-7.78
Net Income From Continuing Operations12.9519.7414.446.000.379.426.69-6.95
Net Income12.9519.7414.446.000.379.426.69-6.95
EPS (Recurring)0.240.330.280.110.020.190.14-0.15
EPS (Basic, Before Extraordinaries)0.260.400.300.120.010.190.14-0.14
EPS (Diluted)0.260.400.290.120.010.190.14-0.14
EBITDA55.5049.8744.0134.8034.8027.2427.438.85
Non-Operating Income (Expense)6.244.156.205.864.993.85-3.635.14
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense12.299.317.828.996.089.256.1712.04
Price To Earnings Ratio30.0475.6653.76130.5854.9234.3034.4824.17
Price To Sales Ratio0.450.600.340.390.480.510.670.74
Gross Margin10.549.109.358.278.5310.8510.396.37
Operating Margin3.903.532.961.942.013.113.320.11
Net Margin1.272.031.500.630.041.441.08-1.04
Shares Outstanding49.3249.2348.9548.8949.3849.1449.0347.93
Market Capitalization1,596.272,301.171,229.821,244.361,415.441,242.231,554.211,548.75

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments429.59290.83296.31293.59286.51261.17219.80108.02120.92
Short Term Receivables407.57324.80147.75119.7399.3160.6698.9556.4620.12
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets26.1522.8617.4514.8018.6416.7510.328.393.13
Total Current Assets863.31638.50461.51428.12404.46338.58329.07172.86144.16
Net Property, Plant & Equipment93.0746.8844.57128.9868.6348.4626.3812.7213.81
Total Investments and Advances33.1048.8632.5244.4042.6180.8730.0736.0322.65
Long-Term Note Receivable48.7251.2726.4715.9416.514.620.0017.5015.00
Intangible Assets1,136.27537.43350.48345.91329.22326.04341.52272.68293.38
Deferred Tax Assets30.0220.6622.1423.7019.09----
Other Assets44.1831.9617.822.865.9318.911.681.211.63
Total Assets2,248.681,375.55955.50989.91886.45817.49728.71513.00490.64
Short Term Debt Incl. Current Port. of LT Debt55.6715.2824.754.793.9014.1712.590.145.63
Accounts Payable44.8415.179.0710.475.519.556.914.4827.18
Income Tax Payable--0.004.280.004.224.5311.623.20
Other Current Liabilities514.76335.16184.85129.07105.3187.0581.3955.7773.59
Total Current Liabilities615.27365.61218.67148.61114.72114.99105.4272.02109.60
Long Term Debt1,022.46456.56296.26224.58197.09246.39243.9613.520.62
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities35.5125.2126.2137.9249.2310.9618.2719.6224.92
Other Liabilities17.1114.003.5920.2614.780.000.001.1919.19
Total Liabilities1,690.35861.38544.74431.37375.81372.34367.65106.34154.32
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity779.29712.72614.22542.56448.17330.82191.55180.55159.95
Total Shareholders Equity779.29712.72614.22542.56448.17330.82191.55180.55159.95
Accumulated Minority Interest-220.96-198.55-203.4515.9962.48114.32169.51226.12176.37
Total Equity558.33514.17410.77558.55510.64445.15361.06406.66336.31
Total Liabilities & Stockholders Equity2,248.681,375.55955.50989.91886.45817.49728.71513.00490.64
Book Value Per Share15.9414.8713.1111.6510.047.835.335.224.95
Tangible Book Value Per Share-7.303.665.634.222.670.11-4.18-2.66-4.13
Full-Time Employees3,0001,9001,8001,3621,133630555492493
Price to Book Ratio1.852.143.012.607.212.333.453.80-7.93
Return on Assets1.243.706.244.908.094.902.272.16-
Return on Equity3.016.5010.509.0617.7014.507.596.36-
Return on Invested Capital1.253.696.675.8910.686.563.245.5816.07
Quick Ratio1.401.752.112.883.532.943.122.401.32
Current Ratio1.401.752.112.883.532.943.122.401.32

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income58.4124.0849.9357.8545.7446.05122.3217.6760.27
Depreciation63.0545.7527.9317.7517.5417.5218.3518.7519.30
Other Funds (Non Cash)48.3952.1642.2028.4631.3229.60-98.707.0617.93
Funds from Operations172.26117.69115.8191.6180.32100.8435.3536.6889.15
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-58.07-3.10-63.61-23.391.80-30.5010.81-22.77-63.05
Income Taxes Payable----6.92-14.01-0.30-7.098.42
Cash from Operating Activities114.19114.6052.2068.2382.1370.3346.1613.9126.10
Capital Expenditures-14.78-10.11-8.03-28.53-22.94-19.22-1.16-1.04-1.17
Net Assets From Acquisitions-6.88-548.60-146.30-6.59-21.40-4.06-11.35-49.40-16.71
Sale of Fixed Assets and Businesses0.000.000.150.000.440.050.050.030.03
Purchase or Sale of Investments0.0015.10-12.36-6.6828.1132.3791.61-119.00-0.41
Purchase of Investments0.000.00-12.48-7.18-3.96-41.62-11.76-119.00-0.41
Sale Or Maturity of Investments0.0015.100.120.4932.0773.99103.370.000.00
Other Uses0.00-1.71-26.00-26.470.000.00-0.14-11.43-7.50
Other Sources5.726.320.262.684.075.9816.500.000.00
Cash from Investing Activities-15.93-539.00-192.28-65.60-11.7215.1295.49-180.84-25.76
Cash Dividends Paid-2.68-7.88-4.04-62.07-14.03-31.09-51.32-61.72-17.76
Change in Capital Stock-19.32-15.430.09-8.67-0.6243.4610.27-3.69-0.85
Repurchase of Common Pref Stock-19.32-15.43-0.94-10.19-9.25-5.74-0.54-7.57-5.05
Sale of Common Pref Stock0.000.001.031.528.6349.2010.803.884.20
Proceedsfrom Stock Options0.000.000.270.000.0040.130.000.750.20
Issuance or Reduction of Debt, Net-127.86604.81144.1675.24-0.83-58.69-9.61228.717.41
Change in Long Term Debt-127.86604.81144.1675.24-0.83-58.69-9.61281.357.90
Issuance of Long Term Debt0.001,100.10171.88280.603.60179.840.00283.838.00
Reduction of Long Term Debt-127.86-495.29-27.71-205.36-4.43-238.53-9.61-2.48-0.10
Net Financing Active Other Cash Flow-11.53-12.15-5.18-1.000.000.00-1.040.000.00
Other Financing Activities Uses-13.83-14.45-5.18-1.000.000.00-1.040.000.00
Cash from Financing Activities-161.40569.35135.043.50-15.47-46.33-51.70163.30-11.20
Net Change in Cash-63.13144.94-5.056.1254.9339.1389.96-3.63-10.86
Free Cash Flow99.42104.4944.1739.7059.1951.1145.0012.8724.93
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow18.3512.6837.69-29.88166.62--104.90
Deferred Taxes & Investment Tax Credit--4.29-4.25-12.44-14.287.67-6.62-6.80-8.35

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments398.44402.14478.38429.59463.45342.12
Short Term Receivables554.40492.51500.07407.57397.02365.28
Inventories0.000.000.000.000.000.00
Other Current Assets27.1324.5125.6526.1523.1621.75
Total Current Assets979.97919.161,004.10863.31883.63729.15
Net Property, Plant & Equipment114.41101.7693.4893.0790.1048.43
Total Investments and Advances31.9832.7632.1733.1029.4651.90
Intangible Assets1,118.921,130.311,131.921,136.271,148.33522.65
Deferred Tax Assets---30.02--
Other Assets48.7748.8248.0944.1837.2041.85
Total Assets2,343.432,282.082,358.832,248.682,237.191,442.35
Short Term Debt Incl. Current Port. of LT Debt70.4462.7955.4255.6755.0517.82
Accounts Payable54.73108.0254.3344.8458.5014.33
Income Tax Payable2.562.082.51-4.92-
Other Current Liabilities658.33574.75633.11514.76511.47427.60
Total Current Liabilities786.07747.64745.37615.27629.93459.75
Long Term Debt906.94916.621,009.771,022.461,032.20429.77
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities7.638.797.4035.514.432.59
Other Liabilities11.2910.4418.8317.1115.9112.29
Total Liabilities1,711.931,683.501,781.371,690.351,682.46904.40
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity856.62830.22800.27779.29775.54765.46
Total Shareholders Equity856.62830.22800.27779.29775.54765.46
Accumulated Minority Interest-225.12-231.65-222.81-220.96-220.82-227.51
Total Equity631.50598.58577.46558.33554.72537.95
Total Liabilities & Stockholders Equity2,343.432,282.082,358.832,248.682,237.191,442.35
Book Value Per Share17.3716.8716.3515.9415.7015.58
Tangible Book Value Per Share-5.32-6.10-6.78-7.30-7.554.94
Full-Time Employees---3,000--
Price to Book Ratio1.852.841.541.581.821.64
Return on Assets2.322.181.641.240.541.87
Return on Equity6.515.083.913.011.293.50
Return on Invested Capital0.731.130.800.330.020.79
Quick Ratio1.251.231.351.401.401.59
Current Ratio1.251.231.351.401.401.59

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income20.2718.4513.136.561.0810.22
Depreciation15.6215.5515.4816.4015.606.90
Other Funds (Non Cash)19.115.4911.0512.7411.6915.80
Funds from Operations54.0440.3141.5736.3425.4031.32
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-37.77-7.5726.49-39.22-15.4559.58
Cash from Operating Activities16.2732.7568.06-2.899.9690.90
Capital Expenditures-3.83-3.88-4.00-3.06-2.55-1.42
Net Assets From Acquisitions-3.09-3.740.00-0.05-548.550.03
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.0015.10-0.08
Purchase of Investments0.000.000.000.000.000.02
Sale Or Maturity of Investments0.000.000.000.0015.10-0.10
Other Uses0.000.000.000.00-0.66-1.05
Other Sources1.121.391.162.062.191.47
Cash from Investing Activities-5.80-6.23-2.84-1.06-534.47-1.05
Cash Dividends Paid-0.93-0.10-0.10-1.56-0.10-0.78
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.47-1.46-2.91-15.430.001.01
Repurchase of Common Pref Stock0.47-1.46-2.91-15.430.001.32
Sale of Common Pref Stock0.000.000.000.000.00-0.30
Proceedsfrom Stock Options0.000.000.000.000.00-0.30
Issuance or Reduction of Debt, Net-11.97-91.97-11.97-11.97653.37-2.98
Change in Long Term Debt-11.97-91.97-11.97-11.97653.37-2.98
Issuance of Long Term Debt0.000.000.000.00705.340.00
Reduction of Long Term Debt-11.97-91.97-11.97-11.97-51.97-2.98
Net Financing Active Other Cash Flow-2.60-10.55-0.982.61-4.78-5.92
Other Financing Activities Uses-2.60-10.37-1.170.31-4.78-5.92
Cash from Financing Activities-15.03-104.07-15.96-26.34648.49-8.67
Net Change in Cash-4.55-77.5549.25-30.28123.9881.19
Free Cash Flow12.4428.8764.06-5.957.4089.48
Price to Free Cash Flow18.3524.977.8912.7215.8110.90

Revenue breakdown

Health Care Capitation2024: 1.86B 2025: 2.92B
Health Care, Other2024: 86.22M 2025: 86.20M
Health Care, Patient Service2024: 62.33M 2025: 112.64M
Management Service2024: 13.98M 2025: 30.39M
Product and Service, Other2024: 15.22M 2025: 28.28M
United States2024: 2.03B 2025: 3.18B
Care Delivery2024: 136.67M 2025: 250.74M
Care Enablement2024: 155.45M 2025: 246.66M
Care Partners2024: 1.95B 2025: 3.02B
Consolidation, Policy2024: -206.61M 2025: -338.24M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-307.89%3.0M38.0M390.85K
2026-10-157.93%3.0M38.0M446.11K
2026-09-307.87%3.1M39.3M502.01K
2026-09-158.34%3.3M39.3M555.19K
2026-08-318.36%3.3M39.2M594.20K
2026-08-148.12%3.2M39.2M606.41K
2026-07-317.21%2.8M39.2M603.29K
2026-07-156.83%2.7M39.2M592.60K
2026-06-306.81%2.7M39.2M539.39K
2026-06-155.96%2.4M39.6M463.34K
2026-05-296.06%2.4M39.6M492.27K
2026-05-156.86%2.7M39.6M493.07K
2026-04-307.32%2.9M39.1M503.96K
2026-04-156.89%2.7M39.0M521.14K
2026-03-317.42%2.9M38.6M539.69K
2026-03-136.73%2.6M38.6M570.26K
2026-02-277.57%2.9M38.6M524.86K
2026-02-137.35%2.8M38.6M551.02K
2026-01-306.63%2.6M38.7M569.05K
2026-01-156.58%2.6M38.9M520.47K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call12.5017.8021.8022.366.6171.000.000.958-0.1020.005
call15.0015.4019.300.005.5450.000.000.948-0.1000.006
call17.5012.9016.800.004.6640.000.000.937-0.0960.007
call20.0010.4014.2016.943.8261.000.000.924-0.0920.008
call22.508.6011.700.003.1700.000.000.906-0.0870.009
call25.006.109.2015.772.5724.000.000.881-0.0800.011
call30.001.553.708.051.19911.000.000.659-0.1530.019
call35.000.252.551.551.7262060.000.434-0.1770.021
call40.000.050.300.121.0421,0020.000.119-0.0560.011
call45.000.001.000.801.4204,3700.000.094-0.0640.009
call50.000.000.050.211.5926620.000.072-0.0600.007
call55.000.002.000.851.4831580.000.019-0.0180.002
call60.000.002.105.001.67916.000.000.017-0.0190.002
call65.000.002.150.001.8560.000.000.016-0.0200.002
call70.000.002.100.002.0170.000.000.015-0.0200.002
put12.500.002.150.004.1680.000.00-0.042-0.1000.005
put15.000.002.150.003.4590.000.00-0.052-0.0980.006
put17.500.002.150.302.86450.000.00-0.063-0.0940.007
put20.000.001.200.502.34651.000.00-0.076-0.0900.008
put22.500.001.450.901.88232.000.00-0.094-0.0840.009
put25.000.000.501.251.45634.000.00-0.119-0.0770.011
put30.000.002.250.801.59655.000.00-0.341-0.1500.019
put35.003.003.603.860.8622551.00-0.566-0.1740.021
put40.006.308.906.701.6272420.00-0.881-0.0520.011
put45.0012.5013.208.801.55337.000.00-0.906-0.0590.009
put50.0015.9019.6015.912.3980.000.00-0.978-0.0120.003
put55.0020.8024.6020.503.2631.000.00-0.981-0.0120.002
put60.0025.8029.700.003.6280.000.00-0.983-0.0130.002
put65.0030.8034.200.003.5580.000.00-0.984-0.0130.002
put70.0035.8039.900.004.2670.000.00-0.985-0.0130.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-10-30SCHEDULE 13G/ASEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-10SEC
2026-10-084Statement of changes in beneficial ownership of securities2026-10-06SEC
2026-10-084Statement of changes in beneficial ownership of securities2026-10-06SEC
2026-10-064Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-09-238-KCurrent report2026-09-23SEC
2026-09-238-KCurrent report2026-09-22SEC
2026-09-174Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-158-KCurrent report2026-09-15SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-05SEC
2026-09-084Statement of changes in beneficial ownership of securities2026-09-05SEC
2026-09-014Statement of changes in beneficial ownership of securities2026-08-31SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-08-113Initial statement of beneficial ownership of securities2026-08-07SEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-07SEC
2026-08-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-07-31SCHEDULE 13GSEC
2026-07-138-KCurrent report2026-07-13SEC
2026-07-018-KCurrent report2026-06-25SEC
2026-06-304Statement of changes in beneficial ownership of securities2026-06-27SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-11S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.13.92%
VANGUARD PORTFOLIO MANAGEMENT LLC5.26%
VANGUARD CAPITAL MANAGEMENT LLC3.93%
STATE STREET CORP3.51%
DIMENSIONAL FUND ADVISORS LP3.31%
325 CAPITAL LLC3.25%
WELLINGTON MANAGEMENT GROUP LLP2.61%
GEODE CAPITAL MANAGEMENT, LLC2.45%
FMR LLC1.99%
BANK OF AMERICA CORP /DE/1.72%

Funds

Fund% owned
iShares Core S&P Small-Cap ETF5.16%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.86%
iShares Russell 2000 ETF2.39%
VANGUARD SMALL-CAP INDEX FUND2.06%
VANGUARD SMALL-CAP GROWTH INDEX FUND1.19%
Fidelity Small Cap Index Fund1.01%
VANGUARD EXTENDED MARKET INDEX FUND0.98%
iShares Russell 2000 Growth ETF0.85%
DIAMOND HILL SMALL CAP FUND0.83%
Select Health Care Services Portfolio0.81%

OakChart. ASTH. Cached 15 minutes.